GMT Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,158,337
Closed -$17.7M 108
2018
Q2
$17.7M Sell
1,158,337
-1,052,500
-48% -$18.2M 0.42% 56
2018
Q1
$43.9M Sell
2,210,837
-756,800
-26% -$13.1M 1.05% 27
2017
Q4
$55.5M Sell
2,967,637
-89,800
-3% -$1.8M 1.13% 26
2017
Q3
$65.7M Buy
3,057,437
+52,300
+2% +$828K 1.32% 22
2017
Q2
$29.4M Buy
3,005,137
+660,637
+28% +$4.29M 0.63% 52
2017
Q1
$13.9M Buy
2,344,500
+1,637,300
+232% +$7.87M 0.29% 70
2016
Q4
$2.79M Buy
+707,200
New +$5.18M 0.06% 101

Other funds holding DVAX

GMT Capital's DVAX Position: Q3 2018 in Review

GMT Capital sold out of Dynavax Technologies (DVAX) in Q3 2018, closing a stake of 1,158,337 shares — an estimated $17.7M sold.

GMT Capital first reported a position in DVAX in Q4 2016 and held it in 7 quarters. The position peaked at $65.7M in Q3 2017. 150 funds tracked by Wall St. Rank hold DVAX as of Q3 2018.

  • GMT Capital reported no remaining Dynavax Technologies position as of Q3 2018 after selling out during the quarter.
  • GMT Capital sold 1,158,337 Dynavax Technologies shares in Q3 2018, an estimated $17.7M.
  • GMT Capital first reported a position in Dynavax Technologies in Q4 2016 and held it in 7 quarters.
  • GMT Capital's Dynavax Technologies position peaked at $65.7M in Q3 2017.
  • 150 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2018.

Based on GMT Capital's 13F filing for Q3 2018, filed 14 Nov 2018.